companydata.dkcompanydata.dk

Freya Biosciences License ApS: Financial statements 2021

CVR: 41372079

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Freya Biosciences License ApS (CVR 41372079) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -37,500 and a net result of DKK -37,500. Equity in the 2021 report amounted to DKK 19,456. The solvency ratio was 52.6%.

Revenue
DKK 0
Gross Profit
DKK -37,500
Profit/Loss
DKK -37,500
Equity
DKK 19,456
Total Assets
DKK 36,956

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Freya Biosciences License ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Freya Biosciences License ApS publishes interim reportJul 15, 2021

Freya Biosciences License ApS has published its interim report for the period May 19, 2020 to December 31, 2020.

About Freya Biosciences License ApS

Freya Biosciences License ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. In 2025, the company reported a gross profit of DKK -14,000 and a net result of DKK -14,000 compared with DKK -30,358 the year before. Equity in the 2025 report amounted to DKK 357,000.

Source: annual report 2025, Danish Business Authority

Other financial years